CASPOFUNGIN ACTAVIS Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin actavis

actavis group ptc ehf - caspofungin - pdr/conc/soln for infus - 50 milligram - caspofungin

CASPOFUNGIN ACTAVIS Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin actavis

actavis group ptc ehf - caspofungin - pdr/conc/soln for infus - 70 milligram - caspofungin

Caspofungin 50mg powder for concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin 50mg powder for concentrate for solution for infusion

flynn pharma limited - caspofungin - powder for concentrate for solution for infusion - 50 milligram(s) - other antimycotics for systemic use; caspofungin

Caspofungin 70mg powder for concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin 70mg powder for concentrate for solution for infusion

flynn pharma limited - caspofungin - powder for concentrate for solution for infusion - 70 milligram(s) - other antimycotics for systemic use; caspofungin

Caspofungin 50mg powder for concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin 50mg powder for concentrate for solution for infusion

wockhardt uk limited - caspofungin - pdr/conc/soln for infus - 50 milligram(s) - other antimycotics for systemic use; caspofungin

Caspofungin 70mg powder for concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin 70mg powder for concentrate for solution for infusion

wockhardt uk limited - caspofungin - pdr/conc/soln for infus - 70 milligram(s) - other antimycotics for systemic use; caspofungin

Caspofungin Accord European Union - English - EMA (European Medicines Agency)

caspofungin accord

accord healthcare s.l.u. - caspofungin acetate - candidiasis; aspergillosis - antimycotics for systemic use - treatment of invasive candidiasis in adult or paediatric patients.treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and/or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Caspofungin 50 mg powder for concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin 50 mg powder for concentrate for solution for infusion

macarthys laboratories limited - caspofungin - powder for concentrate for solution for infusion - 50.00 milligram(s) - other antimycotics for systemic use; caspofungin

Caspofungin 70 mg powder for concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

caspofungin 70 mg powder for concentrate for solution for infusion

macarthys laboratories limited - caspofungin - powder for concentrate for solution for infusion - 70.00 milligram(s) - other antimycotics for systemic use; caspofungin

MYCAMINE POWDER FOR SOLUTION Canada - English - Health Canada

mycamine powder for solution

astellas pharma canada inc - micafungin sodium - powder for solution - 50mg - micafungin sodium 50mg - echinocandins